小程序
传感搜
传感圈

This Healthtech Is Collecting Test Samples From Your Doorstep

2022-07-16
关注

Dial back time to the most isolating weeks and months over the past two years when stepping outside the house, even to purchase medicines, induced anxiety for fear of getting infected with COVID-19. A significant demand for e-pharmacies and virtual doctor consultations arose, as did that for home-collection of samples for Covid tests due to the realization that physically going to a lab meant exposing oneself to the virus. Thus was born Flebo.in, a health-tech startup to provide sample collection services.

Ashish Vikram, co-founder and CEO, Flebo.in

"There was no professional company doing this job. Labs started to employ independent contractors for home collection but customers were always apprehensive about the quality of services: do the home collection agents (phlebotomists) come on time or keep you waiting? Do they use good quality equipment? And so on," recounts Ashish Vikram, co-founder and CEO, Flebo.in.

"Flebo.in was started to provide professional, high-quality phlebotomy services for all labs. The customer can compare labs and choose the best one based on reputation, price, turnaround time and proximity. Our phlebotomists use FDA-certified tools such as patented needles and syringes that self-destruct after the first use to make reusing needles impossible," he continues, adding, "Preventive tests are often skipped by busy Indians because of their hectic lifestyles. We require only five minutes of a person's time at a time and place of their choosing, thus eliminating all excuses for not getting tested regularly."

To achieve such efficiency, Vikram and his team had to build a good pipeline of candidates for hiring high-quality phlebotomists who were focussed on customer satisfaction. An in-house training program ensured these people (both male and female) were skilled and trained for the job, a process informed by customer feedback and a variable salary system based on performance.

"Another big challenge was around building an AI-based IT platform that would handle everything including data integrations with different labs, taking customer bookings, assignment and routing of phlebotomists, enabling customer feedback, tracking on-time collections and report deliveries and automatically calculating employee salaries as well as managing a customer wallet and refunding customers in case of errors or delays."

Initially, the founders used their own funds to finance this venture. They believed in its potential and did not want to go for external funding before proving the entire value proposition, including signing labs, building a pipeline for hiring and training phlebotomists, etc.

"We therefore launched in Delhi NCR as a proof of concept and have in fact demonstrated all of the above. More than 90 per cent of our customers have given us a 4.5 star on a rating with an average rating of 4. Having proved the value proposition, at this point, we do not see any challenges with funding that will allow us to expand country wide. We are in active discussions with multiple VCs," reveals Vikram.

Flebo.in plans to quickly expand its lab aggregator business to support as many pin codes in the country as possible over the next two years.

参考译文
这个健康科技正在从你家门口收集测试样本
让我们回到过去两年中最孤立的几周和几个月,当走出家门,甚至购买药物时,都会因为担心感染COVID-19而产生焦虑。对电子药店和虚拟医生咨询的大量需求出现了,对家庭收集样本进行Covid测试的需求也出现了,因为人们意识到,去实验室意味着将自己暴露在病毒中。Flebo就这样诞生了。当时还没有专业的公司从事这项工作。实验室开始雇佣独立的承包商来上门取血,但客户总是担心服务质量:上门取血代理(抽血师)是准时来还是让你久等?他们使用的设备质量好吗?等等,& # 34;Flebo联合创始人兼首席执行官阿希什•维克拉姆说道。开始为所有实验室提供专业、高质量的抽血服务。客户可以比较实验室,并选择最好的一个基于信誉,价格,周转时间和邻近。我们的抽血医生使用fda认证的工具,如专利针头和注射器,第一次使用后自毁,使重复使用针头不可能,"他继续说道,并补充说,由于繁忙的生活方式,繁忙的印度人经常跳过预防性检测。我们只需要一个人在他们选择的时间和地点的五分钟时间,从而消除所有不定期进行检测的借口。为了实现这样的效率,维克拉姆和他的团队必须建立一个良好的候选人管道,以雇佣高质量的抽血师,他们专注于客户满意度。一个内部培训计划确保这些人(包括男性和女性)熟练并接受了工作培训,一个根据客户反馈和业绩变化的薪酬系统。另一个巨大的挑战是围绕建立一个基于人工智能的IT平台,该平台将处理所有事情,包括与不同实验室的数据集成,接受客户预订,分配和安排抽血医生,实现客户反馈,跟踪准时收款和报告交付,自动计算员工工资,以及管理客户钱包,并在出现错误或延误时退还客户。最初,创始人使用自己的资金来资助这家企业。他们相信它的潜力,并不想在证明整个价值之前寻求外部融资,包括签约实验室,建立招聘和培训抽血师的渠道等。因此,我们在德里推出了NCR,作为概念的证明,实际上已经证明了上述所有的概念。超过90%的客户给了我们4.5星的评分,平均为4星。在证明了价值主张之后,在这一点上,我们没有看到任何资金方面的挑战,这将允许我们在全国范围内扩张。我们正在与多家风投公司积极讨论,"该公司计划在未来两年内迅速扩大其实验室聚合业务,以支持国内尽可能多的pin码。
您觉得本篇内容如何
评分

评论

您需要登录才可以回复|注册

提交评论

提取码
复制提取码
点击跳转至百度网盘